We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$71.2B
Turnover
9.3%
1-Year Est. Return
41.74%
This Fund
S&P 500
This Quarter
Est. Return
+0.97%
1 Year Est. Return
+41.74%
3 Year Est. Return
+120.47%
5 Year Est. Return
+149.18%
10 Year Est. Return
–
AUM
$40.1B
AUM Growth
-$4.93B
(-11%)
Cap. Flow
-$4.88B
Cap. Flow
% of AUM
-12.17%
Top 10 Holdings %
Top 10 Hldgs %
19.14%
Holding
959
New
32
Increased
238
Reduced
614
Closed
39
Avg Time Held
1.7
years
Top 10 Avg Time Held
1.3
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$192M |
| 2 |
Fiserv Inc
FISV
|
+$93.4M |
| 3 |
American Express
AXP
|
+$91.1M |
| 4 |
Prologis
PLD
|
+$86.5M |
| 5 |
AbbVie
ABBV
|
+$84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$197M |
| 3 |
Apple
AAPL
|
+$164M |
| 4 |
RTN
Raytheon Company
RTN
|
+$154M |
| 5 |
Chevron
CVX
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Financials | 15.72% |
| 3 | Consumer Discretionary | 12.22% |
| 4 | Healthcare | 10.98% |
| 5 | Communication Services | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
501
Loews
L
$22.4B
| $7.63M | 0.02% |
148,177
-149,860
| -50% | -$7.74M |
2017 Q3
8 quarters
|
|
502
AES
AES
$10.7B
| $7.62M | 0.02% |
466,396
-776,539
| -62% | -$12.5M |
2017 Q3
8 quarters
|
|
503
Equifax
EFX
$18.8B
| $7.54M | 0.02% |
53,613
-523
| -1% | -$73.7K |
2017 Q3
8 quarters
|
|
504
Expeditors International
EXPD
$25.9B
| $7.5M | 0.02% |
100,908
-166,941
| -62% | -$12.2M |
2017 Q3
8 quarters
|
|
505
McCormick & Company Non-Voting
MKC
$12.5B
| $7.49M | 0.02% |
95,856
-1,070
| -1% | -$86K |
2017 Q3
8 quarters
|
|
506
Freeport-McMoran
FCX
$103B
| $7.49M | 0.02% |
781,948
-14,670
| -2% | -$151K |
2017 Q3
8 quarters
|
|
|
IRCP
507
DELISTED
IRSA Propiedades Comerciales S.A.
IRCP
| $7.49M | 0.02% |
2,473,614
+9,677
| +0.4% | +$36.6K |
2017 Q4
7 quarters
|
|
508
J.M. Smucker
SJM
$13.6B
| $7.47M | 0.02% |
67,870
-14,908
| -18% | -$1.66M |
2017 Q3
8 quarters
|
|
509
Church & Dwight Co
CHD
$24.5B
| $7.45M | 0.02% |
98,974
-168,480
| -63% | -$12.8M |
2017 Q3
8 quarters
|
|
510
Broadridge
BR
$19.6B
| $7.41M | 0.02% |
59,550
-77,183
| -56% | -$9.94M |
2018 Q1
6 quarters
|
|
511
Take-Two Interactive
TTWO
$38.7B
| $7.4M | 0.02% |
59,045
+4,880
| +9% | +$609K |
2018 Q1
6 quarters
|
|
512
Keysight
KEYS
$57.9B
| $7.31M | 0.02% |
75,181
+998
| +1% | +$92.5K |
2018 Q2
5 quarters
|
|
|
BSMX
513
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
| $7.27M | 0.02% |
1,153,037
-323,200
| -22% | -$2.22M |
2018 Q2
5 quarters
|
|
514
Neurocrine Biosciences
NBIX
$14B
| $7.27M | 0.02% |
80,688
-19,608
| -20% | -$1.83M |
2018 Q3
4 quarters
|
|
515
DELISTED
Ansys
ANSS
| $7.25M | 0.02% |
32,763
-30,041
| -48% | -$6.33M |
2017 Q3
8 quarters
|
|
516
C.H. Robinson
CHRW
$16.9B
| $7.16M | 0.02% |
84,466
-48,720
| -37% | -$4.09M |
2017 Q3
8 quarters
|
|
517
SL Green Realty
SLG
$3.38B
| $7.15M | 0.02% |
90,337
-93,964
| -51% | -$7.31M |
2017 Q3
8 quarters
|
|
518
Align Technology
ALGN
$10.7B
| $7.03M | 0.02% |
38,856
+992
| +3% | +$206K |
2017 Q3
8 quarters
|
|
519
JD.com
JD
$36.6B
| $7M | 0.02% |
248,180
-123,459
| -33% | -$3.73M |
2017 Q3
8 quarters
|
|
520
Eastman Chemical
EMN
$7.23B
| $7M | 0.02% |
94,802
-80,974
| -46% | -$5.81M |
2017 Q3
8 quarters
|
|
521
Bunge Global
BG
$20.6B
| $6.95M | 0.02% |
122,708
+4,602
| +4% | +$257K |
2017 Q3
8 quarters
|
|
522
Viatris
VTRS
$21.1B
| $6.92M | 0.02% |
349,791
-177,895
| -34% | -$3.49M |
2017 Q3
8 quarters
|
|
523
Lincoln National
LNC
$7.77B
| $6.83M | 0.02% |
113,275
-3,598
| -3% | -$215K |
2017 Q3
8 quarters
|
|
524
Everest Group
EG
$14.7B
| $6.81M | 0.02% |
25,594
-736
| -3% | -$186K |
2017 Q3
8 quarters
|
|
525
Mettler-Toledo International
MTD
$32.8B
| $6.8M | 0.02% |
9,660
-149
| -2% | -$109K |
2017 Q3
8 quarters
|
|
Similar funds
Aberdeen Group's Q3 2019 Portfolio in Review
As of Q3 2019, Aberdeen Group held 959 positions worth $40.1B, down 11% from $45B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Aberdeen Group withdrew a net $4.88B in Q3 2019, closing 39 positions and reducing 614 holdings. Its most notable exit was L3Harris, an estimated $88.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Aberdeen Group opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $40.7M.
- Aberdeen Group's largest Q3 2019 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,493,397 shares worth $40.7M.
- Aberdeen Group added most to Fidelity National Information Services in Q3 2019, an estimated $192M increase.
- Aberdeen Group's biggest Q3 2019 reduction was Wells Fargo, cutting an estimated $206M.
- Aberdeen Group fully exited L3Harris in Q3 2019, selling an estimated $88.4M.
- Aberdeen Group's ten largest holdings make up 19% of its $40.1B portfolio in Q3 2019.
- Aberdeen Group opened 32 new positions and closed 39 in Q3 2019.
- Aberdeen Group's portfolio value fell 11% quarter-over-quarter to $40.1B.
Based on Aberdeen Group's 13F filing for Q3 2019, filed 13 Nov 2019.